Aprogen Biologics' largest shareholder Aprogen reports major contract shares ratio change from 13.17% to 34.05%

Total shares held by largest shareholder Aprogen and its special relations unchanged at 30,287,399 shares (82.79%)
Shares under major contracts increased from 4,818,513 (13.17%) to 12,459,253 (34.05%)
Reason: changes in collateral contracts and convertible bond sale contracts by special relations
Aprogen entered into three stock pledge agreements with Onli Holdings Loan (total 1,199,999 shares, loans of 3 billion won)
Jade New Technology Fund No. 79 entered into multiple convertible bond sale agreements (relating to 11,259,259 shares)